Summit Global Investments’s Catalyst Pharmaceutical CPRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$584K	Sell	23,573 -3,369	-13%	-$80.3K	0.03%	307
2025 Q4	$629K	Sell	26,942 -33,375	-55%	-$743K	0.04%	270
2025 Q3	$1.19M	Buy	60,317 +3,902	+7%	+$80.2K	0.07%	163
2025 Q2	$1.22M	Sell	56,415 -13,586	-19%	-$321K	0.07%	153
2025 Q1	$1.7M	Sell	70,001 -3,880	-5%	-$87.4K	0.12%	101
2024 Q4	$1.54M	Sell	73,881 -3,411	-4%	-$73.3K	0.1%	154
2024 Q3	$1.54M	Buy	77,292 +1,923	+3%	+$35.6K	0.1%	162
2024 Q2	$1.17M	Sell	75,369 -11,333	-13%	-$176K	0.08%	213
2024 Q1	$1.38M	Sell	86,702 -3,810	-4%	-$57.4K	0.1%	151
2023 Q4	$1.52M	Sell	90,512 -6,883	-7%	-$94.1K	0.1%	158
2023 Q3	$1.14M	Buy	97,395 +72,890	+297%	+$975K	0.08%	194
2023 Q2	$329K	Buy	+24,505	New	+$353K	0.02%	404
2021 Q4	–	Sell	-130,000	Closed	-$689K	–	554
2021 Q3	$689K	Buy	130,000 +72,500	+126%	+$396K	0.05%	258
2021 Q2	$331K	Buy	+57,500	New	+$297K	0.02%	441